<DOC>
	<DOCNO>NCT01089179</DOCNO>
	<brief_summary>Objective : An Open-Label , Randomized , 2-Period , 2-Treatment , Crossover , Single- Dose Bioequivalence Study Metformin Hydrochloride Extended Release 500 mg Tablet ( Test formulation , Torrent Pharmaceuticals Ltd. , India ) Versus Glucophage XR® 500 mg Tablet ( Reference formulation , Bristol- Myers Squibb company , USA ) Healthy Volunteers Fed Conditions . Study Design : An Open-Label , Randomised , 2-Period , 2-Treatment , Crossover Study feed condition .</brief_summary>
	<brief_title>Bioequivalence Study Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet Healthy Volunteers Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>The subject qualify study meet follow inclusion criterion . 1 . Male subject range 18 45 year age . 2 . Body weight within ± 15 % ideal weight relate height body frame accord Life Insurance Corporation ( LIC ) Chart . 3 . Subjects normal finding determine baseline history , physical examination vital sign ( blood pressure , pulse rate , respiration rate body temperature ) 4 . Subjects normal finding determine hematological test , serum chemistry , urine analysis , ECG Xray . 5 . Willingness follow protocol requirement evidence write , informed consent . 6 . Agreeing , use medication ( prescription counter ) , include vitamin mineral two week prior study &amp; course study . 7 . No history presence significant alcoholism drug abuse past one year . 8 . Nonsmokers , ex smoker light smoker included. `` Light smoker define someone smoking 10 cigarette less per day , ex smoker someone completely stop smoke least 3 month . The subject qualify study meet follow exclusion criterion : 1 . Requiring medication ailment include enzymemodifying drug Use drug know induce inhibit hepatic drug metabolism ( e.g.s , inducer : barbiturate , carbazepine , phenytoin , glucocorticoid , omeprazole ; inhibitor : selective serotonin reuptake inhibitor ( SSRIs ) , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) within 30 day prior administration study medication . 2 . Any medical surgical condition , might significantly interfere function gastrointestinal tract , bloodforming organ etc . 3 . History cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic psychiatric disease . 4 . Participation clinical drug study bioequivalence study 90 day prior present study . 5 . History malignancy serious disease . 6 . Refusal abstain food ten ( 10 ) hour prior study drug administration first day study period four ( 4 ) additional hour , post dose . 7 . Refusal abstain water one hour pre dose two ( 2 ) hour , post dosing . 8 . Any contraindication blood sampling . 9 . Refusal abstain smoke consumption tobacco product 24 hour dose last sample collection period . Habituation tobacco necessitate uninterrupted tobacco consumption . 10 . Use xanthinecontaining beverage food 48 hour prior drug dose . 11 . Blood donation 90 day prior commencement study . 12 . Subjects positive HIV test , HbsAg HepatitisC test . 13 . Known history allergic reaction Metformin relate drug . 14 . History drug abuse past one year . 15 . Use prescription medication counter product ( include natural food supplement , vitamin , garlic supplement ) within 2 week prior administration study medication , except topical product without systemic absorption .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>